PATENT CLAIM ANALYSIS

Application Number: 16161094
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-07
Patent Classification: ["514", "278000"]

Abstract:
Provided are a pharmaceutical composition for preventing or treating metabolic diseases and a health food for alleviating metabolic diseases, each of which the pharmaceutical composition and the health food includes, a stereoisomer of isonitramine or a derivative thereof, or a racemic mixture of the stereoisomers, wherein such a compound exhibits effects of inhibiting fat content or differentiation of an adipocyte, inhibiting activity of a carbohydrate metabolism enzyme, protecting pancreas, inhibiting blood sugar, and promoting insulin secretion, and thus can be favorably utilized in the treatment of metabolic diseases, such as obesity, diabetes, and hyperlipidemia.

Claim (Index 1):
A method of preventing or treating a metabolic disease in a subject in need thereof, comprising:\n providing a pharmaceutical composition comprising, as an active ingredient, a stereoisomer represented by Formula 1 or a racemic mixture thereof: wherein, in Formula 1, X is selected from the group consisting of a hydrogen atom, a C 1 -C 10  alkyl group, an acyl group, an allyl group, and a benzyl group, wherein, when X is an allyl group, one or more halogen may be substituted for the unsaturated carbon, or when X is R 1  to R 5  are each independently a hydrogen atom, a nitro group, a halogen atom, a cyano group, a hydroxyl group, a dimethylamino group, a methylsulfonylamide group, a trifluoromethyl group, a C 1 -C 3  alkyl group, a C 1 -C 3  alkoxy group, a vinyl group, an aryl group, a phenoxy group, or a benzoxy group;\n Y is selected from the group consisting of a hydrogen atom, a C 1 -C 10  alkyl group, an acyl group, an allyl group, and a benzyl group, wherein, when Y is an allyl group, one or more halogen may be substituted for the unsaturated carbon, or when Y is \n R 1  to R 5  are each independently a hydrogen atom, a nitro group, a halogen atom, a cyano group, a hydroxyl group, a dimethylamino group, a methylsulfonylamide group, a trifluoromethyl group, a C 1 -C 3  alkyl group, a C 1 -C 3  alkoxy group, a vinyl group, an aryl group, a phenoxy group, or a benzoxy group; and\n carbon atoms at the 6 th  position and the 7 th  position are each a chiral center; and \n administering the pharmaceutical composition to the subject, wherein the metabolic disease is prevented or treated.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.72581
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11417252', '14590530', '13452973', '13225855', '14435730']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.702268157676983
- 35 USC 102 Novelty (BERT): 0.4819170811384353
- Combined Prediction Score: 0.6802330500231283
- Mean Citation Score: 211.327378
- Max Citation Score: 215.1554
- Similarity Product: 182.8541125917912

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test